XNAS
BHST
Market cap97mUSD
Jul 09, Last price
2.76USD
1D
-3.50%
1Q
-35.96%
IPO
1,515.93%
Name
Bioharvest Sciences Inc
Chart & Performance
P/E
—
P/S
1.39
EPS
—
Div Yield, %
—
Shrs. gr., 5y
13.64%
Rev. gr., 5y
144.37%
Revenues
35m
+37.00%
Net income
-11m
L-13.77%
CFO
-7m
L+8.11%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Vancouver, Canada, BioHarvest Sciences Inc. and its subsidiaries are active globally, including in Israel, providing nutraceutical products derived from super fruits and cannabis. The company employs a proprietary plant cell growth technology that effectively produces desired active secondary metabolites without needing to cultivate the entire plant. BioHarvest is responsible for the design, development, production, and commercialization of Vinia, a red grape powder nutraceutical, alongside its medical cannabis offerings.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑04 | 2018‑12 | 2018‑04 | 2017‑04 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||